Standard IND-enabling in vitro DMPK package for small molecules

This product brochure outlines Inotiv’s standard IND-enabling in vitro DMPK package designed to support small molecule drug development from lead optimization through to regulatory submission. Discover how integrated absorption, distribution, metabolism, excretion and drug-drug interaction (ADME/DMPK) studies provide critical data for candidate selection and risk assessment. Explore capabilities including Caco-2 permeability, plasma protein binding, metabolic stability, metabolite profiling, CYP inhibition and induction studies, transporter assessments and excretion studies, helping developers generate the data needed to support informed drug development decisions and IND submissions.

Resource details:

Resource type: Product brochure
Page count: 2
Read time: 4 mins